Significant amounts of London's iconic Oxford Street could be pedestrianized by December 2018, if the city's Mayor Sadiq Khan's proposals are met favorably.

Hundreds of thousands of children are to receive a groundbreaking vaccine against the mosquito-borne disease in three African countries. It's hoped the campaign will save many lives, but there are some drawbacks.

Researchers at Oxford University are waiting to get clinical validation for a 30 minutes coronavirus test they developed in their laboratory. They hope that, "in a matter of weeks", hundreds of thousands of tests will be produced by manufacturers.

The French paper Libération speaks to an exiled Uighur who details the brutal persecution campaign led by Chinese authorities, including confirmation of forced sterilisations. Also, the British press is extremely hopeful over a promising Oxford research team's vaccine trial. Plus, find out why Zoom meetings have led to a rise in casual workwear and... a spike in demand for cosmetic surgery!

The Oxford coronavirus vaccine shows a strong immune response in adults in their 60s and 70s, raising hopes that it can protect age groups most at risk from the virus.

Lagos receives doses of Oxford Astrazeneca vaccines from FG

As the world continues to battle the effects of the coronavirus pandemic, health experts and several pharmaceutical companies have come up with vaccines to reduce the effects. Oxford-AstraZeneca vaccine has given a significant boost to the global fight and here are five key things to know about the controversial vaccine.

Oxford scientists said COVID-19 patients were eight times more likely to develop rare blood clotting from the coronavirus than the AstraZeneca vaccine.

BioNTech wants to continue the success of its COVID-19 vaccine and use mRNA technology to develop shots against malaria. But is production in Africa realistic?

The World Health Organization on Wednesday endorsed the RTS,S/AS01 malaria vaccine, the first against the mosquito-borne disease that kills more than 400,000 people a year, mostly African children.

After testing on more than 800,000 children in Malawi, Ghana and Kenya, the WHO has recommended the use of a vaccine against malaria, a disease that kills nearly 400,000 people every year, mostly children under five. The jab is effective against one of the parasites that transmits the disease and reduces the risk of severe cases by 30 percent, which is enough to save tens of thousands of lives. Associated with other methods, it could drastically reduce the number of sick people each year. Could it even contain the epidemic? Our correspondents report.

Scientists in Oxford, UK, say trials for a new malaria vaccine show it could have a "major impact." They hope to start producing doses by 2023.